Moreover, various drug studies have reported that the aggravation of the upstream NLRP3 inflammasome signaling pathway and IL-1β may serve as a neuroprotective potential for cerebral ischemia and CSVD. The gene discussed is NLRP3; the disease is brain ischemia.